| amine metabolic process | GO:0009308 | 45 | 0.107 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.104 | |
| spermatogenesis | GO:0007283 | 284 | 0.098 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.098 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.097 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.097 | Human |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.090 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.080 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.074 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.072 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.066 | |
| mitochondrion organization | GO:0007005 | 134 | 0.065 | Human |
| regulation of organelle organization | GO:0033043 | 289 | 0.064 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.062 | |
| protein ubiquitination | GO:0016567 | 171 | 0.062 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.059 | Human |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.059 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.056 | |
| marginal zone b cell differentiation | GO:0002315 | 2 | 0.056 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.053 | |
| protein catabolic process | GO:0030163 | 221 | 0.051 | |
| protein maturation | GO:0051604 | 176 | 0.050 | |
| t cell activation | GO:0042110 | 289 | 0.049 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.049 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.048 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.047 | Human |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.046 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.046 | |
| cellular homeostasis | GO:0019725 | 240 | 0.046 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.046 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.046 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.045 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.045 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.044 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.044 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.044 | |
| transmembrane transport | GO:0055085 | 412 | 0.043 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.043 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.043 | Human |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.043 | Human |
| jnk cascade | GO:0007254 | 72 | 0.042 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.042 | Human |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.042 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.042 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.041 | |
| immune effector process | GO:0002252 | 321 | 0.041 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.041 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.040 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.040 | Human |
| fat cell differentiation | GO:0045444 | 160 | 0.039 | |
| positive regulation of b cell chemotaxis | GO:2000538 | 2 | 0.039 | |
| regulation of defense response | GO:0031347 | 233 | 0.039 | |
| cation transport | GO:0006812 | 399 | 0.039 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.038 | |
| gonad development | GO:0008406 | 141 | 0.038 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.038 | |
| regulation of protein localization | GO:0032880 | 231 | 0.037 | |
| protein processing | GO:0016485 | 163 | 0.037 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.037 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.036 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.036 | |
| regulation of b cell chemotaxis | GO:2000537 | 2 | 0.036 | |
| locomotory behavior | GO:0007626 | 195 | 0.035 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.035 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.035 | Human |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.034 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.034 | |
| cation homeostasis | GO:0055080 | 212 | 0.034 | |
| circulatory system process | GO:0003013 | 197 | 0.034 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.033 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.033 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.033 | |
| microtubule based process | GO:0007017 | 236 | 0.033 | |
| myosin filament assembly | GO:0031034 | 2 | 0.032 | |
| membrane organization | GO:0061024 | 245 | 0.032 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.032 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.032 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.031 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.031 | |
| cellular response to lipid | GO:0071396 | 145 | 0.031 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.031 | |
| t cell differentiation | GO:0030217 | 174 | 0.031 | |
| blood circulation | GO:0008015 | 195 | 0.031 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.030 | |
| regulation of ion transport | GO:0043269 | 215 | 0.030 | |
| cytokine production | GO:0001816 | 319 | 0.030 | |
| camera type eye development | GO:0043010 | 266 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.030 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.030 | Human |
| stress activated mapk cascade | GO:0051403 | 80 | 0.030 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.030 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.029 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.029 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.029 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.029 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.029 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.029 | |
| regulation of system process | GO:0044057 | 200 | 0.029 | |
| male sex differentiation | GO:0046661 | 109 | 0.029 | |
| dna metabolic process | GO:0006259 | 303 | 0.029 | Human |
| synaptic transmission | GO:0007268 | 329 | 0.029 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.029 | |
| organelle localization | GO:0051640 | 179 | 0.029 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.028 | Human |
| calcium ion transport | GO:0006816 | 159 | 0.028 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.028 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.028 | Human |
| ion transmembrane transport | GO:0034220 | 361 | 0.028 | |
| organelle assembly | GO:0070925 | 177 | 0.028 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.027 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.027 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.027 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.027 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.027 | |
| extracellular structure organization | GO:0043062 | 148 | 0.027 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.027 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.027 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.027 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.027 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.026 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.026 | Human |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.026 | |
| maintenance of location | GO:0051235 | 89 | 0.026 | |
| germ cell development | GO:0007281 | 185 | 0.026 | |
| endocytosis | GO:0006897 | 168 | 0.026 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.026 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.026 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.026 | |
| oxidation reduction process | GO:0055114 | 342 | 0.026 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.026 | Human |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.026 | |
| skeletal system development | GO:0001501 | 356 | 0.026 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.025 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.025 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.025 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.025 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.025 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.025 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.025 | |
| cell growth | GO:0016049 | 130 | 0.025 | Human |
| protein localization to organelle | GO:0033365 | 185 | 0.025 | |
| inflammatory response | GO:0006954 | 244 | 0.025 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.025 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.025 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.025 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.025 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.025 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.024 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.024 | |
| nuclear division | GO:0000280 | 158 | 0.024 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.024 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.024 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.024 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.024 | |
| chromatin organization | GO:0006325 | 206 | 0.024 | Human |
| nuclear membrane organization | GO:0071763 | 4 | 0.024 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.024 | Human |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.024 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.023 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.023 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.023 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.023 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.023 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.023 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.023 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.023 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.023 | |
| translation | GO:0006412 | 93 | 0.023 | |
| mapk cascade | GO:0000165 | 281 | 0.023 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.023 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.023 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.022 | |
| connective tissue development | GO:0061448 | 179 | 0.022 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.022 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.022 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.022 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.022 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.022 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.022 | |
| organ growth | GO:0035265 | 117 | 0.022 | |
| regulation of cell activation | GO:0050865 | 289 | 0.022 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.022 | |
| digestive system development | GO:0055123 | 200 | 0.022 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.022 | |
| placenta development | GO:0001890 | 140 | 0.022 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.022 | Human |
| sequestering of calcium ion | GO:0051208 | 18 | 0.021 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.021 | Human |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.021 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.021 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.021 | |
| forebrain development | GO:0030900 | 302 | 0.021 | |
| digestive tract development | GO:0048565 | 190 | 0.021 | |
| muscle tissue development | GO:0060537 | 308 | 0.021 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.021 | |
| gland development | GO:0048732 | 330 | 0.021 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.021 | |
| innate immune response | GO:0045087 | 157 | 0.021 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.021 | |
| chromatin modification | GO:0016568 | 187 | 0.021 | |
| cell fate commitment | GO:0045165 | 210 | 0.021 | |
| regulation of secretion | GO:0051046 | 274 | 0.021 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.021 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.021 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.021 | |
| multicellular organism growth | GO:0035264 | 161 | 0.021 | |
| male gamete generation | GO:0048232 | 285 | 0.020 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.020 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.020 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.020 | |
| sensory perception | GO:0007600 | 245 | 0.020 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.020 | |
| cell adhesion | GO:0007155 | 329 | 0.020 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.020 | |
| axonogenesis | GO:0007409 | 274 | 0.020 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.020 | |
| regulation of cell growth | GO:0001558 | 91 | 0.020 | Human |
| leukocyte migration | GO:0050900 | 124 | 0.020 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.020 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.019 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.019 | Human |
| nucleoside metabolic process | GO:0009116 | 246 | 0.019 | Human |
| phospholipid metabolic process | GO:0006644 | 87 | 0.019 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.019 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.019 | |
| response to peptide | GO:1901652 | 136 | 0.019 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.019 | |
| skin development | GO:0043588 | 220 | 0.019 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.019 | |
| positive regulation of vasodilation | GO:0045909 | 3 | 0.019 | |
| positive regulation of growth | GO:0045927 | 104 | 0.019 | Human |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.019 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.019 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.018 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.018 | |
| negative regulation of growth | GO:0045926 | 99 | 0.018 | |
| lateral inhibition | GO:0046331 | 1 | 0.018 | |
| protein secretion | GO:0009306 | 111 | 0.018 | |
| molting cycle | GO:0042303 | 90 | 0.018 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.018 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.018 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.018 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.018 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.018 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.018 | |
| regulation of cell motility | GO:2000145 | 236 | 0.018 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.018 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.018 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.018 | |
| regulation of cell migration | GO:0030334 | 219 | 0.018 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.018 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.018 | Human |
| regulation of metal ion transport | GO:0010959 | 106 | 0.018 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.018 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.018 | |
| response to monosaccharide | GO:0034284 | 67 | 0.018 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.018 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.018 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.018 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.017 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.017 | Human |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.017 | |
| b cell chemotaxis | GO:0035754 | 3 | 0.017 | |
| cellular response to sterol depletion | GO:0071501 | 4 | 0.017 | |
| activation of immune response | GO:0002253 | 138 | 0.017 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.017 | |
| ossification | GO:0001503 | 216 | 0.017 | |
| b cell activation | GO:0042113 | 161 | 0.017 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.017 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.017 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.017 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.017 | |
| response to radiation | GO:0009314 | 165 | 0.017 | |
| response to peptide hormone | GO:0043434 | 127 | 0.017 | |
| chemotaxis | GO:0006935 | 247 | 0.017 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.017 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.017 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 30 | 0.017 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.017 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.016 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.016 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.016 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.016 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.016 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.016 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.016 | Human |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.016 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.016 | |
| intracellular protein transport | GO:0006886 | 204 | 0.016 | |
| response to insulin | GO:0032868 | 100 | 0.016 | |
| organelle fission | GO:0048285 | 170 | 0.016 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.016 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.016 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.016 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.016 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.016 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.016 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.016 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.016 | |
| peptide transport | GO:0015833 | 133 | 0.016 | |
| hepatocyte growth factor receptor signaling pathway | GO:0048012 | 3 | 0.016 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.016 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.016 | |
| tissue homeostasis | GO:0001894 | 115 | 0.016 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.016 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.016 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.016 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.015 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.015 | |
| urogenital system development | GO:0001655 | 261 | 0.015 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.015 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.015 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.015 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.015 | |
| heart morphogenesis | GO:0003007 | 178 | 0.015 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.015 | |
| compound eye development | GO:0048749 | 1 | 0.015 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.015 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.015 | |
| liver development | GO:0001889 | 66 | 0.015 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.015 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.015 | Human |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.015 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.015 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.015 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.015 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.015 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.015 | |
| cellular response to peptide | GO:1901653 | 92 | 0.015 | |
| response to steroid hormone | GO:0048545 | 56 | 0.015 | |
| synapse organization | GO:0050808 | 125 | 0.015 | |
| endomembrane system organization | GO:0010256 | 147 | 0.015 | |
| histone modification | GO:0016570 | 159 | 0.015 | |
| regionalization | GO:0003002 | 337 | 0.015 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.015 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.015 | Human |
| regulation of tube size | GO:0035150 | 57 | 0.015 | |
| heart process | GO:0003015 | 94 | 0.015 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.014 | |
| response to oxygen levels | GO:0070482 | 62 | 0.014 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.014 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.014 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.014 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.014 | |
| positive regulation of protein ubiquitination | GO:0031398 | 27 | 0.014 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.014 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.014 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.014 | |
| response to drug | GO:0042493 | 75 | 0.014 | |
| neuron death | GO:0070997 | 154 | 0.014 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.014 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.014 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.014 | |
| negative regulation of release of cytochrome c from mitochondria | GO:0090201 | 6 | 0.014 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.014 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.014 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.014 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.014 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.014 | |
| developmental maturation | GO:0021700 | 193 | 0.014 | |
| mature b cell differentiation involved in immune response | GO:0002313 | 9 | 0.014 | |
| regulation of inositol trisphosphate biosynthetic process | GO:0032960 | 3 | 0.014 | |
| regulation of ossification | GO:0030278 | 112 | 0.014 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.014 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.014 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.014 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.014 | |
| b cell differentiation | GO:0030183 | 78 | 0.014 | |
| angiogenesis | GO:0001525 | 201 | 0.014 | |
| neuron migration | GO:0001764 | 122 | 0.014 | |
| hindbrain development | GO:0030902 | 128 | 0.013 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.013 | |
| cgmp biosynthetic process | GO:0006182 | 13 | 0.013 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.013 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.013 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.013 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.013 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.013 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.013 | |
| cardiac chamber development | GO:0003205 | 108 | 0.013 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.013 | |
| t cell proliferation | GO:0042098 | 120 | 0.013 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.013 | |
| regulation of anoikis | GO:2000209 | 2 | 0.013 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.013 | |
| rna processing | GO:0006396 | 105 | 0.013 | Human |
| neuromuscular process | GO:0050905 | 99 | 0.013 | |
| mrna metabolic process | GO:0016071 | 84 | 0.013 | Human |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.013 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.013 | Human |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.013 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.013 | |
| protein targeting | GO:0006605 | 143 | 0.013 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.013 | |
| cognition | GO:0050890 | 149 | 0.013 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.013 | |
| epithelial cell development | GO:0002064 | 159 | 0.013 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.013 | Human |
| cardiocyte differentiation | GO:0035051 | 87 | 0.013 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.013 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.013 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.013 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.012 | |
| learning or memory | GO:0007611 | 148 | 0.012 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.012 | |
| response to estrogen | GO:0043627 | 24 | 0.012 | |
| gonad morphogenesis | GO:0035262 | 1 | 0.012 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.012 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.012 | |
| localization within membrane | GO:0051668 | 4 | 0.012 | |
| phagocytosis | GO:0006909 | 66 | 0.012 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.012 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.012 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.012 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.012 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.012 | |
| rhythmic process | GO:0048511 | 174 | 0.012 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.012 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.012 | |
| hair cycle | GO:0042633 | 90 | 0.012 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.012 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.012 | |
| defense response to other organism | GO:0098542 | 197 | 0.012 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.012 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.012 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.012 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.012 | Human |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.012 | |
| dna repair | GO:0006281 | 107 | 0.012 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.012 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.012 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.012 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.012 | |
| regulation of translation | GO:0006417 | 71 | 0.012 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.012 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.012 | |
| dephosphorylation | GO:0016311 | 129 | 0.012 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.012 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.012 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.012 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.012 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.012 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.012 | |
| gastrulation | GO:0007369 | 116 | 0.011 | |
| biomineral tissue development | GO:0031214 | 64 | 0.011 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.011 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.011 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.011 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.011 | |
| male gonad development | GO:0008584 | 88 | 0.011 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.011 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.011 | |
| methylation | GO:0032259 | 134 | 0.011 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.011 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.011 | |
| regulation of organ growth | GO:0046620 | 61 | 0.011 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.011 | |
| striated muscle cell development | GO:0055002 | 125 | 0.011 | |
| nuclear transport | GO:0051169 | 139 | 0.011 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.011 | Human |
| skeletal muscle organ development | GO:0060538 | 163 | 0.011 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.011 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.011 | |
| adult behavior | GO:0030534 | 135 | 0.011 | |
| mesoderm development | GO:0007498 | 100 | 0.011 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.011 | |
| gene silencing | GO:0016458 | 38 | 0.011 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.011 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.011 | |
| cgmp mediated signaling | GO:0019934 | 3 | 0.011 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.011 | Human |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.011 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.011 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.011 | |
| neuronal action potential | GO:0019228 | 54 | 0.011 | |
| renal system development | GO:0072001 | 225 | 0.011 | |
